Skip to main content
SpringerLink
Log in

Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas

  • Regular Papers
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

Monoclonal antibodies (mAbs) recognizing the disialoganglioside II3(NeuAc)2GgOse3Cer (GD2) were produced by immunizing mice with the GD2-expressing neuroblastoma cell line LAN-1 and a prefusion boost with purified GD2 coupled to Salmonella minnesota. Two IgM mAbs were isolated which demonstrated high levels of reactivity (binding ratios in excess of 100) with GD2 by solid-phase radioimmunoassay and positivity in high-performance thin-layer chromatography (HPTLC) immunostain; only one (DMAb-20) was subsequently shown by analysis with a panel of defined ganglioside species to be specific for the minimum epitope of GD2, GalNAcβ1-4(NeuAcα2-8NeuAcα2-3)Gal-. DMAb-20 was used to evaluate the expression of GD2 by malignant glioma and medulloblastoma cell lines using cell surface radioimmunoassay, indirect membrane immunofluorescence, HPTLC immunostain, and densitometric analysis of extracted gangliosides from selected cell lines. Sixteen of 20 (80%) malignant glioma and 5 of 5 medulloblastoma cell lines reacted with DMAb-20; in agreement with previous studies, 5 of 5 neuroblastoma and 2 of 3 melanoma cell lines also reacted with DMAb-20. GD2 was proportionally increased in the glioma and medulloblastoma cell lines relative to levels in normal brain, as determined by densitometric analysis. In a phenotypic survey of malignant glioma biopsies, tumor cells in 24 of 30 (80%) cases stained positively with DMAb-20. Reactive astrocytes, both within and adjacent to tumors, were frequently intensely stained. Among the morphological variants of glioblastoma examined, the most intense staining with DMAb-20 was observed in neoplastic gemistocytes, with the weakest or absent staining in small cell glioblastomas. As GD2 is a commonly expressed surface antigen of gliomas and medulloblastomas, expression of which is retained in tissue culture, DMAb-20 will be useful in determining the functional role of GD2 in cell-cell interaction, adhesion, and invasion, and in defining altered growth control mechanisms of central nervous system neoplasms in in vitro models.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

xxGangliosides have been designated according to CBN recommendations [22] and to the coding system of Svennerholm [35] GD2:

II3(NeuAc)2GgOse3Cer

GM3:

II3NeuAc-LacCer

GD3:

II3(NeuAc)2-LacCer

GM2:

II3NeuAcGgOse3Cer

GM1:

II3NeuAcGgOse4Cer

GD1a:

II3NeuAcIV3NeuAcGgOse4Cer

GD1b:

II3(NeuAc)2GgOse4Cer

GT1b:

IV3NeuAcII3(NeuAc)2GgOse4Cer

GQ1b:

IV3(NeuAc)2II3(NeuAc)2GgOse4Cer

3′,8′-LD1:

IV3(NeuAc)2nLeOse4Cer

References

  1. Ando S, Chang N-C, Yu RK (1978) High-performance thinlayer chromatography and densitometric determination of brain ganglioside composition of several species. Anal Biochem 89:437–450

    Google Scholar 

  2. Bigner DD, Bigner SH, Pontén J, Westermark B, Mahaley MS Jr, Ruoslahti E, Herschman H, Eng LF, Wikstrand CJ (1981) Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 40:201–229

    Google Scholar 

  3. Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD (1990) Amplification of the c-myc gene in medulloblastoma cell lines and xenografts. Cancer Res 50:2347–2350

    Google Scholar 

  4. Bosslet K, Mennel HD, Rodden F, Bauer BL, Wagner F, Altmannsberger A, Sedlacek HH, Wiegandt H (1989) Monoclonal antibodies against epitopes on ganglioside GD2 and its lactones: markers for gliomas and neuroblastomas. Cancer Immunol Immunother 29:171–178

    Google Scholar 

  5. Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD (1983) Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 43:2796–2805

    Google Scholar 

  6. Cahan LD, Irie RF, Singh R, Cassidenti A, Paulson JC (1982) Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. Proc Natl Acad Sci USA 79:7629–7633

    Google Scholar 

  7. Cheresh DA, Harper JR, Schulz G, Reisfeld RA (1984) Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells. Proc Natl Acad Sci USA 81:5767–5771

    Google Scholar 

  8. Cheung N-KV, Saarinen UM, Neely JE, Landmeier B, Donovan D, Coccia PF (1985) Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res 45:2642–2649

    Google Scholar 

  9. Cohen ME, Duffner PK (1984) Brain tumors in children. Principles of diagnosis and treatment. Raven Press, New York, pp 1–8

    Google Scholar 

  10. Dawson G, Stefansson K (1984) Gangliosides of human spinal cord: aberrant composition of cords from patients with amyotrophic lateral sclerosis. J Neurosci Res 12:213–220

    Google Scholar 

  11. Distler JJ, Jourdian GW (1973) The purification and properties of β-galactosidase from bovine testes. J Biol Chem 248:6672–6680

    Google Scholar 

  12. Fredman P, Magnani JL, Nirenberg M, Ginsburg V (1984) Monoclonal antibody A2B5 reacts with many gangliosides in neuronal tissue. Arch Biochem Biophys 233:661–666

    Google Scholar 

  13. Fredman P, von Holst H, Collins VP, Ammar A, Dellheden B, Wahren B, Granholm L, Svennerholm L (1986) Potential ganglioside antigens associated with human gliomas. Neurol Res 8:123–126

    Google Scholar 

  14. Fredman P, M»nsson J-E, Bigner S, Wikstrand C, Bigner D, Svennerholm L (1990) Gangliosides in the human ghoma cell line U-118 MG grown in culture or as xenografts in nude rats. Biochim Biophys Acta 1045:239–244

    Google Scholar 

  15. Friedman HS, Burger PC, Bigner SH, Trojanowski JW, Wikstrand CJ, Halperin EC Bigner DD (1985) Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med. J Neuropathol Exp Neurol 44:592–605

    Google Scholar 

  16. Friedman HS, Burger PC, Bigner SH, Trojanowski JW, Brodeur GM, He X, Wikstrand CJ, Kurtzberg J, Berens ME, Halperin EC, Bigner DD (1988) Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc. Am J Pathol 130:472–484

    Google Scholar 

  17. Gillard BK, Thomas JW, Nell LJ, Marcus DM (1989) Antibodies against ganglioside GT3 in the sera of patients with type 1 diabetes mellitus. J Immunol 142:3826–3832

    Google Scholar 

  18. Gross N, Beck D, Portoukalian J, Favre S, Carrel S (1989) New anti-GD2 monoclonal antibodies produced from gammainterferon treated neuroblastoma cells. Int J Cancer 43:665–671

    Google Scholar 

  19. Hakomori S (1985) Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res 45:2405–2414

    Google Scholar 

  20. Heiner JP, Miraldi F, Kallick S, Makley J, Neely J, Smith-Mensah WH, Cheung N-KV (1987) Localization of GD2-specific monoclonal antibody 3F8 in human osteosarcoma. Cancer Res 47:5377–5381

    Google Scholar 

  21. Hsu S-M, Raine L, Fanger H (1981) Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29:577–580

    Google Scholar 

  22. IUPAC-IUB Commission on Biochemical Nomenclature (CBN) (1977) The nomenclature of lipids. Eur J Biochem 79:11–21

    Google Scholar 

  23. Jacobsen PF, Jenkyn DJ, Papadimitriou JM (1985) Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol 44:472–485

    Google Scholar 

  24. Kawashima I, Tada N, Ikegami S, Nakamura S, Ueda R, Tai T (1988) Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas. Int J Cancer 41:267–274

    Google Scholar 

  25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  26. Mujoo K, Cheresh DA, Yang HM, Reisfeld RA (1987) Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth. Cancer Res 47:1098–1104

    Google Scholar 

  27. Mujoo K, Kipps TJ, Yang HM, Cheresh DA, Wargalla U, Sander DJ, Reisfeld RA (1989) Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch of monoclonal anti-ganglioside GD2 antibody 14.18. Cancer Res 49:2857–2861

    Google Scholar 

  28. Olsson Y, Sourander P, Svennerholm L (1966) Experimental studies on the pathogenesis of leucodystrophies. I. The effect of intracerebrally injected sphingolipids in the rat's brain. Acta Neuropathol (Berl) 6:153–163

    Google Scholar 

  29. Richter A, Sanford KK, Evans VJ (1972) Influence of oxygen and culture media on plating efficiency of some mammalian tissue cells. J Natl Cancer Inst 49:1705–1712

    Google Scholar 

  30. Rosengren B, M»nsson J-E, Svennerholm L (1987) Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?. J Neurochem 49:834–840

    Google Scholar 

  31. Schulz G, Cheresh DA, Varki NM, Yu A, Staffileno LK, Reisfeld GA (1984) Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res 44:5914–5920

    Google Scholar 

  32. Slagel DE, Dittmer JC, Wilson CB (1967) Lipid composition of human glial tumor and adjacent brain. J Neurochem 14:789–798

    Google Scholar 

  33. Suzuki K (1965) The pattern of mammalian brain gangliosides. III. Regional and developmental differences. J Neurochem 12:969–979

    Google Scholar 

  34. Svennerholm L (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta 24:604–611

    Google Scholar 

  35. Svennerholm L (1963) Chromatographic separation of human brain gangliosides. J Neurochem 10:613–623

    Google Scholar 

  36. Svennerholm L (1970) Gangliosides. In: Lajtha A (ed) Handbook of neurochemistry, vol 3, Plenum Press, New York, pp 425–452

    Google Scholar 

  37. Svennerholm L, Fredman P (1980) A procedure for the quantitative isolation of brain gangliosides. Biochim Biophys Acta 617:97–109

    Google Scholar 

  38. Tai T, Kawashima I, Tada N, Dairiki K (1988) Different fine binding specificities of monoclonal antibodies to disialoganglioside GD2. J Biochem 103:682–687

    Google Scholar 

  39. Thurin J, Thurin M, Kimoto Y, Herlyn M, Lubeck MD, Elder DE Smereczynski M, Karlson K-A, Clark WM, Steplewski Z, Koprowski H (1987) Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. Cancer Res 47:1229–1233

    Google Scholar 

  40. Traylor TD, Hogan EL (1980) Gangliosides of human cerebral astrocytomas. J Neurochem 34:126–131

    Google Scholar 

  41. Vrionis FD, Wikstrand CJ, Fredman P, M»nsson J-E, Svennerholm L, Bigner DD (1989) Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. Cancer Res 49:6645–6651

    Google Scholar 

  42. Wikstrand CJ, Bigner DD (1982) Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies. Cancer Res 42:267–272

    Google Scholar 

  43. Wikstrand CJ, Mahaley MS, Bigner DD (1977) Surface antigenic characteristics of human glial brain tumor cells. Cancer Res 37:4267–4275

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Duke University Medical Center, Box 3156, 27710, Durham, NC, USA

    D. C. Longee, C. J. Wikstrand, X. He, G. N. Fuller, S. H. Bigner & D. D. Bigner

  2. Preuss Laboratory for Brain Tumor Research, Duke University Medical Center, Box 3156, 27710, Durham, NC, USA

    D. D. Bigner

  3. Department of Psychiatry and Neurochemistry, Gothenburg University, St. Jörgen Hospital, S-42203, Hisings Backa, Sweden

    J. -E. M»nsson, P. Fredman & L. Svennerholm

Authors
  1. D. C. Longee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. J. Wikstrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. -E. M»nsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X. He
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. N. Fuller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. H. Bigner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Fredman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L. Svennerholm
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D. D. Bigner
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported in part by NIH Grants R37 CA 11898, NS 20023, CA 32672, and T32-NS 07304, and by a grant from the Swedish Medical Research Council (Project 03X-627). Dr. Longee is an Association of Medical School Pediatric Department Chairmen, Inc., Pediatric Scientist Training Program Fellow supported by St. Jude Children's Research Hospital

Rights and permissions

Reprints and permissions

About this article

Cite this article

Longee, D.C., Wikstrand, C.J., M»nsson, J.E. et al. Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas. Acta Neuropathol 82, 45–54 (1991). https://doi.org/10.1007/BF00310922

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00310922

Key words

Search

Navigation